Ampersand Capital Partners Named to Inc.’s 2023 List of Founder-Friendly Investors

[ad_1] WELLESLEY, Mass., Nov. 6, 2023 /PRNewswire/ — For the second consecutive year, Ampersand Capital Partners was named to Inc.’s 2023 Founder-Friendly Investors list, which honors the private equity and…

P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO

[ad_1] LEUVEN, Belgium, May 2, 2023 /PRNewswire/ — P95 BV, a global provider of epidemiology and clinical research solutions with a focus on vaccines and infectious diseases, today announced a…